{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T14:07:14Z","timestamp":1767276434945},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089415","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T22:51:00Z","timestamp":1396479060000},"page":"e89415","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Optimising Assessments of the Epidemiological Impact in the Netherlands of Paediatric Immunisation with 13-Valent Pneumococcal Conjugate Vaccine Using Dynamic Transmission Modelling"],"prefix":"10.1371","volume":"9","author":[{"given":"Elisabetta","family":"De Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Melegaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier","family":"Klok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"WP Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"DS Fedson","year":"1999","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-007-0417-y","article-title":"Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation","volume":"27","author":"E Bingen","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11908-007-0047-7","article-title":"Changing epidemiology of bacterial meningitis","volume":"9","author":"MA Dery","year":"2007","journal-title":"Curr Infect Dis Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.82.6.445","article-title":"Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides","volume":"82","author":"CM Macleod","year":"1945","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/520068","article-title":"Robert Austrian: 1917\u20132007","volume":"45","author":"JO Klein","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"T Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"E Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2010.137802","article-title":"Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997\u20132008","volume":"65","author":"E Koshy","year":"2010","journal-title":"Thorax"},{"key":"ref10","first-page":"18","article-title":"Invasive pneumococcal disease in Australia, 2006","volume":"32","author":"PW Roche","year":"2008","journal-title":"Commun Dis Intell Q Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"AM van Deursen","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref12","unstructured":"Cox CM (2012) Early impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease, United States, 2010\u201311. Presented at the 1st National Immunization Conference Online, March 26\u201328, 2012 (presentation 30196). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/cdc.confex.com\/cdc\/nic2012\/webprogram\/Paper30196.html\" xlink:type=\"simple\">https:\/\/cdc.confex.com\/cdc\/nic2012\/webprogram\/Paper30196.html<\/ext-link> (accessed 2013 June 24)."},{"key":"ref13","unstructured":"Public Health England. Pneumococcal Disease. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Pneumococcal\/\" xlink:type=\"simple\">http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Pneumococcal\/<\/ext-link> (accessed 2013 June 24)."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate vaccine","volume":"174","author":"R Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination","volume":"348","author":"SK Obaro","year":"1996","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine","volume":"180","author":"N Mbelle","year":"1999","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"CG Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.inf.0000069760.65826.f2","article-title":"Vaccination of day-care center attendees reduces carriage of <italic>Streptococcus pneumoniae<\/italic> among their younger siblings","volume":"22","author":"N Givon-Lavi","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1086\/425422","article-title":"Impact of a conjugate vaccine on community-wide carriage of nonsusceptible <italic>Streptococcus pneumoniae<\/italic> in Alaska","volume":"190","author":"MR Moore","year":"2004","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.inf.0000133046.60555.de","article-title":"Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine","volume":"23","author":"TR Talbot","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"S Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"CA Lexau","year":"2005","journal-title":"JAMA"},{"key":"ref23","first-page":"18","article-title":"Invasive pneumococcal disease in Australia, 2006","volume":"32","author":"PW Roche","year":"2008","journal-title":"Commun Dis Intell Q Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"DM Weinberger","year":"2011","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(01)00063-9","article-title":"Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance","volume":"1","author":"KP Klugman","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1586\/erv.12.99","article-title":"Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions","volume":"11","author":"RA Farkouh","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1016\/j.vaccine.2012.10.017","article-title":"The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England","volume":"30","author":"AJ van Hoek","year":"2012","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1524-4733.2007.00225.x","article-title":"Cost-utility of repeated screening for <italic>Chlamydia trachomatis<\/italic>","volume":"11","author":"R de Vries","year":"2008","journal-title":"Value Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e13392","DOI":"10.1371\/journal.pone.0013392","article-title":"Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model","volume":"5","author":"R de Vries","year":"2010","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1016\/j.vaccine.2012.06.026","article-title":"Cost-effectiveness of pertussis booster vaccination in the Netherlands","volume":"30","author":"MH Rozenbaum","year":"2012","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-10-90","article-title":"Dynamic models of pneumococcal carriage and the impact of the heptavalent pneumococcal conjugate vaccine on invasive pneumococcal disease","volume":"10","author":"A Melegaro","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e26190","DOI":"10.1371\/journal.pone.0026190","article-title":"7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?","volume":"6","author":"YH Choi","year":"2011","journal-title":"PloS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"J Mossong","year":"2008","journal-title":"PloS Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.vaccine.2010.01.005","article-title":"Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar)","volume":"28","author":"MH Rozenbaum","year":"2010","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2334-6-14","article-title":"<italic>S. pneumoniae<\/italic> transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools","volume":"6","author":"S Cauchemez","year":"2006","journal-title":"BMC Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/aje\/kwm076","article-title":"Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data","volume":"166","author":"A Melegaro","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref37","unstructured":"van Lier EA, Oomen PJ, Mulder M, Conyn-van Spaendonck MA, Drijfhout IH, <etal>et al<\/etal>.. (2013) Vaccinatiegraad Rijksvaccinatieprogramma Nederland: Verslagjaar 2013. RIVM Rapport 150202001. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.rivm.nl\/dsresource?objectid=rivmp:209251&type=org&disposition=inline&ns_nc=1\" xlink:type=\"simple\">http:\/\/www.rivm.nl\/dsresource?objectid=rivmp:209251&amp;type=org&amp;disposition=inline&amp;ns_nc=1<\/ext-link> (accessed 2013 June 24)."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.2009.975","article-title":"Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial","volume":"302","author":"EJ van Gils","year":"2009","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3201\/eid1704.101115","article-title":"Carriage of <italic>Streptococcus pneumoniae<\/italic> 3 years after start of vaccination program, the Netherlands","volume":"17","author":"J Spijkerman","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e39927","DOI":"10.1371\/journal.pone.0039927","article-title":"Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales","volume":"7","author":"YH Choi","year":"2012","journal-title":"PloS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"c2509","DOI":"10.1136\/bmj.c2509","article-title":"Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines","volume":"340","author":"MH Rozenbaum","year":"2010","journal-title":"BMJ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":"Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials","volume":"374","author":"R Prymula","year":"2009","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2010.12.086","article-title":"Impact of the 10-valent pneumococcal non-typeable <italic>Haemophilus influenzae<\/italic> protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage","volume":"29","author":"R Prymula","year":"2011","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.vaccine.2013.01.044","article-title":"Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable <italic>Haemophilus influenzae<\/italic> protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol","volume":"31","author":"R Prymula","year":"2013","journal-title":"Vaccine"},{"key":"ref45","unstructured":"Hammitt LL, Akech DO, Morpeth SC, Kihuha N, Karani A, <etal>et al<\/etal>.. (2012) Reductions in nasopharyngeal carriage of <italic>Streptococcus pneumoniae<\/italic> and <italic>Haemophilus influenzae<\/italic> 6 months after introduction of PCV10 in Kilifi, Kenya. Presented at the 8th International Symposium on Pneumococci and Pneumococcal Diseases, March 11\u201315, Igua\u00e7u Falls, Brazil (poster 242). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www2.kenes.com\/ISPPD\/Scientific\/Documents\/FinalAbstractbook.pdf\" xlink:type=\"simple\">http:\/\/www2.kenes.com\/ISPPD\/Scientific\/Documents\/FinalAbstractbook.pdf<\/ext-link> (accessed 2013 June 24)."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"E Miller","year":"2011","journal-title":"Vaccine"},{"key":"ref47","unstructured":"Moore M, Link-Gelles R, Farley MM, Schaffner W, Thomas A, <etal>et al<\/etal>.. (2012) Impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease, U.S, 2010-11. Presented at IDWeek\u2122 2012, October 17\u201321, San Diego, CA, USA (abstract 1219). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/idsa.confex.com\/idsa\/2012\/webprogram\/Paper36569.html\" xlink:type=\"simple\">https:\/\/idsa.confex.com\/idsa\/2012\/webprogram\/Paper36569.html<\/ext-link> (accessed 2013 June 24)."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.vaccine.2013.03.049","article-title":"Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010\u20132020","volume":"31","author":"R Link-Gelles","year":"2013","journal-title":"Vaccine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:51:05Z","timestamp":1540216265000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089415"}},"subtitle":[],"editor":[{"given":"Shamala Devi","family":"Sekaran","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089415","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}